Survivors (n = 125) | Nonsurvivors (n = 67) | P | |
---|---|---|---|
Gender female: number (%) | 40 (31.2) | 24 (37.5) | 0.27 |
Age: median years (percentile 25-75) | 56 (47-69) | 62 (52-71) | 0.15 |
Diabetes mellitas: number (%) | 25 (19.8) | 24 (37.5) | 0.02 |
COPD: number (%) | 17 (13.5) | 10 (15.6) | 0.67 |
Site of infection | 0.82 | ||
• Respiratory: number (%) | 67 (53.2) | 38 (59.4) | |
• Abdominal: number (%) | 28 (22.2) | 13 (20.3) | |
• Other sites: number (%) | 31(24.6) | 13 (20.3) | |
APACHE-II score: median (percentile 25-75) | 19 (14-22) | 24 (18-29) | <0.001 |
Creatinine (mg/dl): median (percentile 25-75) | 1.2 (0.80-2.05) | 1.6 (0.9-2.8) | 0.02 |
Leukocytes: median/mm3 (percentile 25-75) | 14,600 (8,900-20,050) | 15,200 (9,050-20,625) | 0.39 |
Lactic acid: median mmol/L (percentile 25-75) | 2,00 (1.20-3.70) | 3.95 (1.47-6.55) | <0.001 |
Platelets: median/mm3 (percentile 25-75) | 210,000 (127,000-273,000) | 139,000 (63,000-218,250) | <0.001 |
INR: median (percentile 25-75) | 1.27 (1.10-1.50) | 1.42 (1.10-1.66) | 0.17 |
aPTT: median seconds (percentile 25-75) | 30 (26-39) | 39 (30-47) | <0.001 |
SOFA store: median (percentile 25-75) | 9 (7-11) | 12 (9-14) | <0.001 |
• Respiratory: median (percentile 25-75) | 3 (2-3) | 3 (2-3) | 0.07 |
• Hematologic: median (percentile 25-75) | 0 (0-1) | 1 (0-2) | <0.001 |
• Hepatic: median (percentile 25-75) | 0 (0-1) | 0 (0-1) | 0.75 |
• Cardiovascular: median (percentile 25-75) | 4 (4-4) | 4 (4-4) | 0.006 |
• Neurologic: median (percentile 25-75) | 0 (0-1) | 0 (0-3) | 0.22 |
• Renal: median (percentile 25-75) | 0 (0-2) | 2 (0-4) | <0.001 |